Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00382824
Status:
COMPLETED
Last Update Posted:
2019-08-01
First Post:
2006-09-28
Brief Title:
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy PSP
Sponsor:
Lahey Clinic
Organization:
Lahey Clinic
Study Overview
Official Title:
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy PSP A Multicenter Randomized Placebo-controlled Double Blind Study
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinsons Disease PD Currently no effective treatment exists Coenzyme Q10 in high doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial therapy for PSP This study will compare the efficacy safety and tolerability of Coenzyme Q10 versus placebo in patients with atypical parkinsonian syndrome progressive supranuclear palsy PSP
Detailed Description:
The study is designed as a multicenter randomized placebo-controlled double blind trial Up to 60 patients with PSP will be enrolled at several centers in the United States
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None